Accrued Expenses

12 Months Ended

Dec. 31, 2017

7.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

	December 31,
	2017		2016
Accrued clinical operations and trials costs	$	2,003,799	$	1,647,490
Accrued product development costs		1,255,439		713,426
Accrued compensation		1,335,672		778,250
Accrued other		146,609		117,289
Total	$	4,741,519	$	3,256,455